TECHINNOVATION TECH OFFERS

Singapore is an aged society and is set to be “super-aged” in 2026. This means that 21% of the population are 65 years and above. In a recent study conducted in Singapore, 72% had some form of cognitive impairment. The number of young onset dementia is also on the rise in Singapore. This underscores the critical need for early detection and intervention. However, existing screening tools for dementia have limitations. Their ability to identify Mild Cognitive Impairment (MCI), an early stage of dementia, is limited. Additionally, these tools require specialized instructors for test administration and scoring, which can be inconvenient for seniors who must visit a facility for screening. This innovative app merges mobile technology with artificial intelligence to address these challenges. It outperforms the MMSE (mini-mental state examination), the most widely used dementia screening test, in identifying both Alzheimer’s disease and MCI. Furthermore, the AI-based automatic scoring system provides test results within one minute, eliminating the need for specially trained instructors. This feature makes the app accessible anywhere, including at home. By enhancing the accuracy, accessibility, and usability of dementia screening, the app aims to facilitate equitable access to essential healthcare resources and contribute to the well-being of individuals and communities.    

The company offers a suite of innovative automated liquid handling systems, hardware and software for process automation designed to enhance precision, efficiency, and scalability in biological research. The industry currently faces significant challenges with semi or full automation of laboratory equipment, including high costs, limited flexibility, and manual errors. These bottlenecks hinder the efficiency and reliability of complex laboratory processes. The company's technology addresses these issues with a range of flagship products that provide cutting-edge automation for tasks such as genomic and proteomic analysis, drug discovery, and clinical diagnostics. The systems feature modular assembly, allowing for easy customization and scalability to meet the evolving needs of life science laboratories. This flexibility ensures that the solutions can adapt to various experimental setups and requirements. One of the unique value proposition of the company's technology is its ability to significantly reduce costs up to 90% compared to traditional automation systems. This cost-effectiveness is achieved through innovative mechanical design, advanced software integration, and efficient hardware utilization. Additionally, the systems boast the largest consumables library in the industry, providing researchers with a wide range of options to support their specific needs. The company is actively seeking software and OEM partnerships to further enhance its product offerings and expand its market reach. By collaborating with key partners, it aims to continue driving innovation and providing top-tier solutions to the life sciences industry.